These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2311655)

  • 1. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam.
    Imperato A; Puglisi-Allegra S; Zocchi A; Scrocco MG; Casolini P; Angelucci L
    Eur J Pharmacol; 1990 Jan; 175(2):211-4. PubMed ID: 2311655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.
    Imperato A; Angelucci L
    Neurosci Lett; 1989 Jun; 101(2):214-7. PubMed ID: 2549462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine.
    Wozniak KM; Pert A; Linnoila M
    Eur J Pharmacol; 1990 Oct; 187(2):287-9. PubMed ID: 2272364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo voltammetric study of the response of mesocortical and mesoaccumbens dopaminergic neurons to environmental stimuli in strains of rats with differing levels of emotionality.
    Scatton B; D'Angio M; Driscoll P; Serrano A
    Ann N Y Acad Sci; 1988; 537():124-37. PubMed ID: 3059919
    [No Abstract]   [Full Text] [Related]  

  • 5. NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.
    Serrano A; D'Angio M; Scatton B
    Eur J Pharmacol; 1989 Mar; 162(1):157-66. PubMed ID: 2566493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release.
    Carboni E; Acquas E; Frau R; Di Chiara G
    Eur J Pharmacol; 1989 May; 164(3):515-9. PubMed ID: 2767122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.
    Kalivas PW; Abhold R
    Brain Res; 1987 Jun; 414(2):339-48. PubMed ID: 3620936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of stress and ACTH on dopamine metabolism in the nucleus accumbens and frontal cortex.
    Fadda F; Liguori G
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):454-8. PubMed ID: 6263300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.
    Pehek EA
    Synapse; 1996 Sep; 24(1):12-8. PubMed ID: 9046072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.
    Yoshioka M; Matsumoto M; Togashi H; Saito H
    Pharmacol Biochem Behav; 1995; 51(2-3):515-9. PubMed ID: 7667378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning.
    Papp M
    Eur J Pharmacol; 1988 Jul; 151(2):321-4. PubMed ID: 2901973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential decrease in dopamine utilization in prefrontal cortex by zopiclone, diazepam and zolpidem in unstressed rats.
    Boireau A; Dubedat P; Laduron PM; Doble A; Blanchard JC
    J Pharm Pharmacol; 1990 Aug; 42(8):562-5. PubMed ID: 1981584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat.
    Herve D; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1982 Apr; 237(2):510-6. PubMed ID: 6805852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.
    Jiang LH; Ashby CR; Kasser RJ; Wang RY
    Brain Res; 1990 Apr; 513(1):156-60. PubMed ID: 2112416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tail-pinch stress increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the rat nucleus accumbens but not frontal cortex: antagonism by diazepam and zolpidem.
    D'Angio M; Serrano A; Rivy JP; Scatton B
    Brain Res; 1987 Apr; 409(1):169-74. PubMed ID: 3580866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.
    Pehek EA; Nocjar C; Roth BL; Byrd TA; Mabrouk OS
    Neuropsychopharmacology; 2006 Feb; 31(2):265-77. PubMed ID: 15999145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens.
    During MJ; Acworth IN; Wurtman RJ
    Brain Res; 1988 Jun; 452(1-2):378-80. PubMed ID: 3401745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.